Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pradere

Showing results (381-390 of 412) with videos related to

Pageof 42
Sort By:
European Urology Oncology|June 21, 2024
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline PanelsLaura S Mertens, Harman Maxim Bruins, Roberto Contieri, et al.
European Urology Oncology|January 23, 2024
Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant ChemotherapySean A Fletcher, Maximilian Pallauf, Emelia K Watts, et al.
BJU International|March 20, 2026
Refining BCG-failure classifications in non-muscle-invasive bladder cancerAleksander Ślusarczyk, Pietro Scilipoti, Roberto Contieri, et al.
Cancers|March 11, 2023
Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched AnalysisNico C Grossmann, Francesco Soria, Tristan Juvet, et al.
European Urology|January 22, 2025
Intravesical Instillation of Chemotherapy Before Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: The REBACARE TrialThomas van Doeveren, Sebastiaan Remmers, Egbert R Boevé, et al.
European Urology Oncology|December 19, 2025
Predictive Value of Prior Non-muscle-invasive Bladder Cancer for the Effectiveness of Neoadjuvant Chemotherapy in Localized Muscle-invasive Bladder Cancer: A Real-world Analysis of the BLADRAC CohortElisabeth Grobet-Jeandin, Elliott Diamant, Pierre-Etienne Gabriel, et al.
BJU International|March 26, 2025
The impact of histopathological evaluation at transurethral resection of bladder tumour on survival in radical cystectomy candidatesMario de Angelis, Pietro Scilipoti, Alfonso Santangelo, et al.
World Journal of Urology|July 23, 2025
Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinomaLuca Afferi, Benjamin Pradere, Andrea Gallioli, et al.
Cancers|April 12, 2022
Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care MetricsFrederik König, Nico C Grossmann, Francesco Soria, et al.
Minerva Urology and Nephrology|September 20, 2023
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapyRadosław Piszczek, Wojciech Krajewski, Jose D Subiela, et al.
Pageof 42

Showing results (381-390 of 412) with videos related to

Sort By:
Pageof 42
European Urology Oncology|June 21, 2024
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline PanelsLaura S Mertens, Harman Maxim Bruins, Roberto Contieri, et al.
European Urology Oncology|January 23, 2024
Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant ChemotherapySean A Fletcher, Maximilian Pallauf, Emelia K Watts, et al.
BJU International|March 20, 2026
Refining BCG-failure classifications in non-muscle-invasive bladder cancerAleksander Ślusarczyk, Pietro Scilipoti, Roberto Contieri, et al.
Cancers|March 11, 2023
Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched AnalysisNico C Grossmann, Francesco Soria, Tristan Juvet, et al.
European Urology|January 22, 2025
Intravesical Instillation of Chemotherapy Before Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: The REBACARE TrialThomas van Doeveren, Sebastiaan Remmers, Egbert R Boevé, et al.
European Urology Oncology|December 19, 2025
Predictive Value of Prior Non-muscle-invasive Bladder Cancer for the Effectiveness of Neoadjuvant Chemotherapy in Localized Muscle-invasive Bladder Cancer: A Real-world Analysis of the BLADRAC CohortElisabeth Grobet-Jeandin, Elliott Diamant, Pierre-Etienne Gabriel, et al.
BJU International|March 26, 2025
The impact of histopathological evaluation at transurethral resection of bladder tumour on survival in radical cystectomy candidatesMario de Angelis, Pietro Scilipoti, Alfonso Santangelo, et al.
World Journal of Urology|July 23, 2025
Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinomaLuca Afferi, Benjamin Pradere, Andrea Gallioli, et al.
Cancers|April 12, 2022
Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care MetricsFrederik König, Nico C Grossmann, Francesco Soria, et al.
Minerva Urology and Nephrology|September 20, 2023
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapyRadosław Piszczek, Wojciech Krajewski, Jose D Subiela, et al.
Pageof 42